+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Novel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids, 2019-2030 - Product Thumbnail Image

Novel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids, 2019-2030

  • Report
  • January 2019
  • 230 Pages
  • Global
From
Immunomodulators Market - Global Forecast 2025-2032 - Product Thumbnail Image

Immunomodulators Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 185 Pages
  • Global
From
Prostate Cancer Drugs Market Report 2025 - Product Thumbnail Image

Prostate Cancer Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Prostate Cancer Therapeutics Market - Product Thumbnail Image

Prostate Cancer Therapeutics Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Chylomicronemia Syndrome Market - Global Forecast 2025-2032 - Product Thumbnail Image

Chylomicronemia Syndrome Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 193 Pages
  • Global
From
Digital Biomarkers Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Product, Purpose of Solution, Type of Biomarker, Therapeutic Area, Business Model and Key Geographical Regions - Product Thumbnail Image

Digital Biomarkers Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Product, Purpose of Solution, Type of Biomarker, Therapeutic Area, Business Model and Key Geographical Regions

  • Report
  • April 2025
  • 369 Pages
  • Global
From
Bacterial Sialadenitis - Global Strategic Business Report - Product Thumbnail Image

Bacterial Sialadenitis - Global Strategic Business Report

  • Report
  • November 2025
  • 559 Pages
  • Global
From
Morquio Syndrome Drugs - Global Strategic Business Report - Product Thumbnail Image

Morquio Syndrome Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 467 Pages
  • Global
From
Dercum's Disease - Global Strategic Business Report - Product Thumbnail Image

Dercum's Disease - Global Strategic Business Report

  • Report
  • November 2025
  • 383 Pages
  • Global
From
Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 589 Pages
  • Global
From
Brain Tumor Drugs Market Report 2025 - Product Thumbnail Image

Brain Tumor Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Metastatic Hormone Refractory Prostate Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Hormone Refractory Prostate Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 450 Pages
  • Global
From
Molecular Diagnostics Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Molecular Diagnostics Collaboration and Licensing Deals 2016-2025

  • Report
  • May 2025
  • 400 Days
  • Global
From
Nanomedicine Market Report 2025 - Product Thumbnail Image

Nanomedicine Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Hypercholesterolemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hypercholesterolemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 210 Pages
  • Global
From
Heterozygous familial hypercholesterolemia (heFH) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Heterozygous familial hypercholesterolemia (heFH) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 63 Pages
  • Global
From
Glioblastoma Multiforme Treatment Market Size, Share & Trends Analysis Report By Treatment (Radiation Therapy, Immunotherapy), By Drug Class, By End-use, By Region, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Glioblastoma Multiforme Treatment Market Size, Share & Trends Analysis Report By Treatment (Radiation Therapy, Immunotherapy), By Drug Class, By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • September 2023
  • 110 Pages
  • Global
From
Prostate Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

Prostate Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Breast Cancer Therapeutics Market Size and Forecasts 2020-2030, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy, Breast Cancer Type, Distribution Channel, and Geography - Product Thumbnail Image

Breast Cancer Therapeutics Market Size and Forecasts 2020-2030, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy, Breast Cancer Type, Distribution Channel, and Geography

  • Report
  • October 2023
  • 204 Pages
  • Global
From
Brain Tumor Drugs Market Analysis & Forecast 2024-2034: Market; By Therapy; By Indication; By Distribution Channel; and By Region - Product Thumbnail Image

Brain Tumor Drugs Market Analysis & Forecast 2024-2034: Market; By Therapy; By Indication; By Distribution Channel; and By Region

  • Report
  • October 2023
  • 145 Pages
  • Global
From
Loading Indicator